PathAI IBD Explore™ panel will empower drug developers with improved inflammatory microenvironment spatial characterization from H&E, propelling a new phase of precision medicine in IBD  BOSTON — May 17, 2023 —PathAI, a global...

PathAI and ConcertAI: Researchers derive novel insights through the combination of PathAI's proprietary tumor microenvironment features with ConcertAI's multi-modal clinical data BOSTON, April 25, 2023 /PRNewswire/ -- PathAI, a global...

CYPATH is the second largest independent pathology group in France, with nine technical laboratories in the east part of the country. The private group analyzes over 800,000 cases per year with a specialization in histopathology, cytopathology,...

Today, Nature Medicine published groundbreaking Owkin research demonstrating the first-ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data. At Owkin, we are on a journey to...

PictorLabs Launches with More Than $18.8 Million to Advance Transformative Virtual Staining AI-powered virtual staining demonstrates potential to revolutionize histopathology, simplify lab workflows, and accelerate drug discovery Financing...

Visiopharm: Join us on 5 September in Basel, Switzerland for our breakfast symposium at the 2022 European Congress of Pathology (ECP). Learn more about how existing manual processes in the histopathology lab can be optimized to introduce...